Global Patent Index - EP 1085865 A1

EP 1085865 A1 2001-03-28 - USE OF CYTOPROTECTANTS

Title (en)

USE OF CYTOPROTECTANTS

Title (de)

VERWENDUNG VON ZELLSCHUTZMITTELN

Title (fr)

UTILISATION DE CYTOPROTECTEURS

Publication

EP 1085865 A1 (EN)

Application

EP 99943498 A

Priority

  • NO 9900193 W
  • NO 982795 A

Abstract (en)

[origin: WO0000191A1] It is described that flavonoids can be used to produce pharmaceutical preparations for protection of specific groups of living cells against cell death occurring spontaneously, under pathological conditions or as the result of a toxic insult. It is demonstrated that certain flavonoids protect groups of neuronal and liver cells during toxic insults produced by okadaic acid.

IPC 1-7 (main, further and additional classification)

A61K 31/365; A61K 31/70

IPC 8 full level (invention and additional information)

A61K 31/35 (2006.01); A61K 31/352 (2006.01); A61K 38/00 (2006.01)

CPC (invention and additional information)

A61K 31/7048 (2013.01); A61K 31/35 (2013.01); A61K 31/352 (2013.01); A61K 38/005 (2013.01)

Combination set (CPC)

  1. A61K 38/005 + A61K 31/7048
  2. A61K 38/005 + A61K 31/35
  3. A61K 31/7048 + A61K 31/35
  4. A61K 31/35 + A61K 31/35
  5. A61K 31/35 + A61K 2300/00
  6. A61K 31/7048 + A61K 2300/00
  7. A61K 38/005 + A61K 2300/00

Citation (search report)

See references of WO 0000191A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 0000191 A1 20000106; AU 5657399 A 20000117; AU 761488 B2 20030605; CA 2334686 A1 20000106; EP 1085865 A1 20010328; IS 5754 A 20001206; NO 982795 D0 19980617

INPADOC legal status


2004-07-07 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20040102

2002-01-23 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20011210

2001-03-28 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20010115

2001-03-28 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE